id: prison_incarceration_rate_to_prescription_opioid_misuse
name: Prison Incarceration Rate â†’ Prescription Opioid Misuse
from_node:
  node_id: prison_incarceration_rate
  node_name: Prison Incarceration Rate
to_node:
  node_id: prescription_opioid_misuse
  node_name: Prescription Opioid Misuse
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Incarcerated individuals with opioid use disorder receive prescribed opioid agonist treatment
  (e.g., sublingual buprenorphine) for maintenance therapy'
- 'Step 2: Prison environments with reduced access to illicit drugs create scarcity, increasing demand
  for available substances'
- 'Step 3: Prisoners divert prescribed sublingual buprenorphine by retaining tablets and administering
  them nasally'
- 'Step 4: Nasal administration emerges as dominant abuse route due to reduced injection drug use infrastructure
  in prisons'
- 'Step 5: Culture of prescription opioid diversion becomes normalized within prison populations'
evidence:
  quality_rating: B
  n_studies: 10
  primary_citation: 'Zanib Bi-Mohammed et al. 2017. "Prescription opioid abuse in prison settings: A systematic
    review of prevalence, practice and treatment responses." https://doi.org/10.1016/j.drugalcdep.2016.11.032'
  supporting_citations:
  - Additional citations require full-text access - systematic review included 10 papers from 1995-2016
  - Studies from multiple countries including Australia, UK, and other international settings were included
  - Reference lists of identified journals were hand-searched for relevant articles
  doi: 10.1016/j.drugalcdep.2016.11.032
  citation_verified: true
  needs_manual_review: true
  citation_issues:
  - Primary citation doesn't match verified citation from literature search
last_updated: '2025-12-06'
version: '2.0'
description: Incarceration creates conditions where prescribed opioid medications, particularly sublingual
  buprenorphine, are diverted and abused. The prison environment's reduced access to illicit drugs and
  injection equipment leads to alternative abuse routes (nasal administration) becoming culturally normalized.
spatial_variation:
  varies_by_geography: true
  variation_notes: Significant differences in abuse behaviours between different countries were reported,
    suggesting national prison policies and drug availability patterns shape diversion practices
moderators:
- name: illicit_drug_availability
  direction: weakens
  strength: strong
  description: Reduced supplies of illicit drugs within prison increases diversion of prescribed opioids
- name: injection_equipment_access
  direction: strengthens
  strength: moderate
  description: Reduced prevalence of injection within prison leads to nasal administration becoming dominant
    abuse route
- name: medication_formulation
  direction: weakens
  strength: strong
  description: Buprenorphine/naloxone preparation appears less amenable to abuse compared to buprenorphine
    alone
structural_competency:
  equity_implications: This mechanism highlights how carceral institutions create unique drug use environments.
    The scarcity of illicit substances combined with continued addiction needs among incarcerated populations
    drives prescription medication diversion. Rather than framing this as individual moral failing, the
    structural factors of incarceration, limited treatment options, and medication formulation choices
    by healthcare systems shape these behaviors. Healthcare providers in prisons must consider 'least
    abusable' preparations as a structural intervention.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.708219'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
